This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Alkermes Pharma Ireland Limited. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Renato A. Chiarella: Innovator in Pharmaceutical Technology
Introduction
Renato A. Chiarella is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. With a total of 3 patents to his name, Chiarella's work focuses on improving the efficacy and delivery of medications.
Latest Patents
Chiarella's latest patents include advancements in immediate release multilayer tablets. These tablets are designed for the oral delivery of olanzapine and samidorphan. The patents describe methods of using these tablets in the treatment of various disorders, as well as kits that comprise these innovative formulations. His work aims to enhance patient outcomes through improved medication delivery.
Career Highlights
Renato A. Chiarella is currently associated with Alkermes Pharma Ireland Limited, where he continues to push the boundaries of pharmaceutical innovation. His expertise in multilayer tablet technology has positioned him as a key player in the industry. Chiarella's dedication to research and development has led to significant advancements in drug formulation.
Collaborations
Chiarella has collaborated with esteemed colleagues such as David Manser and Paul Hurley. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas. Together, they work towards developing cutting-edge solutions in the pharmaceutical sector.
Conclusion
Renato A. Chiarella's contributions to pharmaceutical technology exemplify the impact of innovation in healthcare. His patents and collaborative efforts continue to shape the future of drug delivery systems. Chiarella's work is a testament to the importance of research and development in improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile